Clinical Trial Update: Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a therapeutic vaccine targeting HPV16 in patients with cervical intraepithelial neoplasia (CIN) 2/3; results have been posted after stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• HPV16 Therapeutic Vaccine

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: HPV16 Positive, Cervical Intraepithelial Neoplasia (CIN 2/3) | Phase 1 | Status: COMPLETED | Results posted: 2018-07-09